CTRI/2019/10/021760
Active, not recruiting
Phase 4
A long-term non-interventional observational study in Living Donor Liver Transplant Recipients (LDLTRs) with primary hepatocellular carcinoma (HCC) treated with Certican® / Zortress® (everolimus; EVR) plus reduced tacrolimus (rTAC) versus standard tacrolimus (sTAC) control
ovartis Healthcare Pvt Ltd0 sites1 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: K742- Hepatic fibrosis with hepatic sclerosis
- Sponsor
- ovartis Healthcare Pvt Ltd
- Enrollment
- 1
- Status
- Active, not recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who have completed 24 month RCT study CRAD001H2307 and had primary HCC at the time of liver transplantation.
- •2\. Patient who signed the informed consent to participate in this NIS.
Exclusion Criteria
- •1\. Patient with a liver graft loss during the 2 years in the CRAD001H2307 study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
An observational, non-interventional cohort study to monitor physical and social activity of bladder cancer patients during treatment with curative intent by using conventional and digital methodologyBladder cancer1003836410004994NL-OMON51316Academisch Medisch Centrum50
Active, not recruiting
Not Applicable
Digital monitoring of bladder cancer patients (eBladder)Bladder cancerCancerISRCTN55744047Amsterdam University Medical Centers50
Completed
Not Applicable
ongitudinal non-interventional observational study on Adherence, safety and tolerability of AVANZ® in adults and GRAZAX® and SLIToneULTRA® in adults and children (5 – 17 years) in patients with allergic Rhinoconjunctivitis in GErmanyJ30.1J30.3Allergic rhinitis due to pollenOther allergic rhinitisDRKS00005069ALK-Abelló Arzneimittel GmbH2,571
Active, not recruiting
Not Applicable
Observational study of a motion capture device (AKIRA) in patients with ALSJPRN-jRCT1030230648Hirai Manabu35
Not yet recruiting
Not Applicable
A non-interventional, prospective study to evaluate change in physical activity, relationship satisfaction and psychological well-being in patients with rheumatoid arthritis after introduction of the JAK inhibitor filgotinib and also in their partners.M06.8Other specified rheumatoid arthritisDRKS00032128Helios Fachklinik Vogelsang-Gommern, Rheumatologie40